tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nordicus Partners Releases Subsidiary Valuation Reports

Story Highlights
  • Nordicus Partners released valuation reports for subsidiaries Orocidin and Bio-Convert.
  • The valuations assist in evaluating fair market value and provide financial insights.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nordicus Partners Releases Subsidiary Valuation Reports

Meet Your ETF AI Analyst

Nordicus Partners ( (NORD) ) just unveiled an announcement.

Nordicus Partners Corporation has released valuation reports for its wholly owned subsidiaries, Orocidin A/S and Bio-Convert A/S, prepared by independent appraisers Stanton Park Advisors LLC. These valuations, available from August 11, 2025, are intended to assist the Board of Directors in evaluating the subsidiaries’ fair market value and provide insights into their financial performance and industry positioning. The reports are not guarantees of future value and are for informational purposes only.

More about Nordicus Partners

Average Trading Volume: 1,160

Technical Sentiment Signal: Sell

Current Market Cap: $31.91M

Learn more about NORD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1